Hypertension ‘a key dangerous factor’ in COVID-19 mortality

Hypertensive patients may be at a greater risk of dying from COVID-19, the viral disease stemming from the world’s largest coronavirus outbreak to date, according to Bloomberg News.

Du Bin, director of the intensive care unit at Peking Union Medical College Hospital in Beijing, was sent to Wuhan, China—the epicenter of the COVID-19 pandemic—last December when the virus was first beginning to spread through local communities. He said that of a group of 170 patients who died of COVID-19 in January in Wuhan, nearly half had hypertension.

“That’s a very high ratio,” he told Bloomberg over the phone from Wuhan. “From what I was told by other doctors and the data I can see myself, among all the underlying diseases, hypertension is a key dangerous factor.”

Du, considered one of the most respected critical care experts in China, did acknowledge that his observation hasn’t been supported by research. Still, he said, he and his team in Wuhan believe hypertension could be “an important factor in causing patients to deteriorate.”

“We’ll keep an eye on old people and those with high blood pressure,” Du said. “They are the key focus.”

Read the full story below:

""

After graduating from Indiana University-Bloomington with a bachelor’s in journalism, Anicka joined TriMed’s Chicago team in 2017 covering cardiology. Close to her heart is long-form journalism, Pilot G-2 pens, dark chocolate and her dog Harper Lee.

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."